Showing results (961-970 of 1,351) with videos related to

Sort By:
Pageof 136
Clinical Pharmacology in Drug Development|February 16, 2026
A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Phase 1 Study of Firsekibart in Chinese Healthy ParticipantsXiaolan Yong, Xiaolin Du, Xiao Li, et al.
Clinical Pharmacology in Drug Development|June 9, 2025
Pharmacokinetics, Bioequivalence, and Safety Studies of Crisaborole Ointment in Healthy Chinese SubjectsYanchao Wang, Xiaofei Zhao, Taixin Wang, et al.
Clinical Pharmacology in Drug Development|June 19, 2025
Taste Profile and Relative Bioavailability of Tovorafenib Powder for Oral Suspension and Food Effect of the Tovorafenib Tablet in Healthy ParticipantsYang Zhang, Mike Preigh, Jing Wang, et al.
Clinical Pharmacology in Drug Development|April 16, 2025
Pharmacokinetics and Safety of a Fixed-Dose Combination of Alogliptin and Extended-Release Metformin Under Fasting and/or Fed Conditions in Healthy AdultsJi Hye Song, Jae Hoon Kim, Jang Hee Hong, et al.
Clinical Pharmacology in Drug Development|March 28, 2025
Population Pharmacokinetics of Butylphthalide Injection in Elderly Chinese Patients With Ischemic StrokeShu-Xian Lyu, Xue-Yan Cui, Shi-Xian Chen, et al.
Clinical Pharmacology in Drug Development|June 10, 2023
Evaluation of the Mass Balance and Metabolic Profile of Futibatinib in Healthy ParticipantsIkuo Yamamiya, Allen Hunt, Fumiaki Yamashita, et al.
Clinical Pharmacology in Drug Development|June 3, 2023
Evaluation of Drug-Drug Interaction Potential of Enarodustat (JTZ-951) Using a Cytochrome P450 Probe CocktailSudhakar M Pai, Hiroyuki Yamada, Hiroyuki Murata
Clinical Pharmacology in Drug Development|March 2, 2026
Pharmacokinetic and Bioequivalence Evaluation of Two Lercanidipine Hydrochloride Tablets in Healthy Chinese VolunteersBiao Sun, Li Zhao, Fangliang Gan, et al.
Clinical Pharmacology in Drug Development|March 25, 2024
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety, and Tolerability After Subcutaneous Administration of Tozorakimab in Healthy Chinese ParticipantsYunfei Li, Hua Zhang, Hitesh Pandya, et al.
Clinical Pharmacology in Drug Development|February 16, 2024
Phase 1 Healthy Volunteer Study of AL01211, an Oral, Non-brain Penetrant Glucosylceramide Synthase Inhibitor, to Treat Fabry Disease and Type 1 Gaucher DiseaseMichael Babcock, Jianhong Zheng, Jessica Gail Shurr, et al.
Pageof 136